Novartis’ Alcon picks up PowerVision for $285m

Novartis’ Alcon picks up PowerVision for $285m

Source: 
Mass Device
snippet: 

Novartis (NYSE:NVS) subsidiary Alcon said today that it acquired intraocular lens developer PowerVision for $285 million.

PowerVision is developing fluid-based intraocular lens implants that use the eye’s natural accommodating response to transport fluid in the implanted lens, Fort Worth, Texas-based Alcon said.